Seer’s finance chief will leave Oct. 1. A company finance VP will take over.

Seer (SEER) announced that CFO David Horn will leave on October 1, 2026, to join a private company. Charles Endweiss, VP of Financial Planning & Analysis, will take over as Treasurer and principal financial officer on the same date. The CEO praised Horn's contributions and Endweiss's expertise.

Original reporting
Published Sep 21, 2026, 11:11 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 11:47 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$SEER
Neutral
medium confidence
Mentioned
$SEER
Relevance
5/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$SEERNeutralLow
01

Why it matters

The CFO transition is a routine leadership change with limited immediate financial impact but could influence future strategic decisions.

02

Market read

The announcement is a primary disclosure of an executive change, modest relevance for traders monitoring Seer.

03

What to watch

Potential hidden cost synergies or strategic shifts under the new CFO are not disclosed.

Relevance 5/10Novelty 6/10Timing: effective Oct 1, 2026

Background

Seer is a Nasdaq‑listed proteomics company that provides deep, unbiased proteomic insights.

Company-level read

Ticker impact

$SEERNeutralMedium confidence
Context

Seer announced that CFO David Horn will depart on Oct. 1, 2026 and VP Charles Endweiss will assume the CFO role.

Expected impact

Potential modest price movement around the announcement; no immediate directional bias.

Evidence & confidence

Executive changes are material but the company is small and the transition is internal, limiting market impact.

Market effects

Minimal; the proteomics sector may note a leadership change but no broader impact.

None; company is US‑based with limited regional exposure.

Low; no global market shift expected.

Counterpoint

The CFO departure could be seen as a risk if the new CFO lacks experience in capital markets.

Key entities

  • David Horn

    Outgoing President, CFO and Treasurer.

  • Charles Endweiss

    Incoming CFO, previously VP of FP&A.

Related articles

$SEERMed

Seer Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Revenue Guidance

Seer, Inc. (SEER) filed an SEC Form 8-K — Results of Operations and Financial Condition. Seer Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Revenue Guidance REDWOOD CITY, Calif. – November 10, 2026 – Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced fin

$SEERMed

Seer wins ITC staff backing for import ban on Nanomics products

Seer, Inc. (SEER) announced that the U.S. International Trade Commission's staff recommended an import ban on Nanomics' products, alleging patent infringement. The ITC is expected to make a final decision by year-end. Seer also reported recent patent victories in the U.S. and Europe. The company develops proteomics technology and is involved in a related lawsuit against Nanomics.